Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors

Presynaptic adenosine A2Areceptors dampen cannabinoid CB1receptor-mediated inhibition of corticostriatal glutamatergic transmission

(2015) S G Ferreira et al.   BRITISH JOURNAL OF PHARMACOLOGY

Allosteric interactions between agonists and antagonists within the adenosine A2Areceptor-dopamine D2receptor heterotetramer

(2015) Jordi Bonaventura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease

(2014) Kjell Fuxe et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Adenosine (A)2A receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach

(2014) Joanna Jastrzębska et al.   NEUROPHARMACOLOGY

Endocannabinoid signaling and food addiction

(2014) C. D’Addario et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety

(2014) Joana E. Coelho et al.   Frontiers in Psychiatry

l-DOPA-treatment in primates disrupts the expression of A2A adenosine–CB1 cannabinoid–D2 dopamine receptor heteromers in the caudate nucleus

(2013) Jordi Bonaventura et al.   NEUROPHARMACOLOGY

A2A adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats

(2012) Maria V. Micioni Di Bonaventura et al.   BEHAVIOURAL PHARMACOLOGY

Adenosine A2A–cannabinoid CB1 receptor interaction: An integrative mechanism in striatal glutamatergic neurotransmission

(2012) Maria Teresa Tebano et al.   BRAIN RESEARCH

The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently

(2012) Alexia Polissidis et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

RGS4 Is Required for Dopaminergic Control of Striatal LTD and Susceptibility to Parkinsonian Motor Deficits

(2012) Talia N. Lerner et al.   NEURON

The endocannabinoid system: an overview

(2012) Natalia Battista et al.   Frontiers in Behavioral Neuroscience

Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington's disease

(2011) Valentina Chiodi et al.   NEUROBIOLOGY OF DISEASE

Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease

(2011) Marie Therese Armentero et al.   PHARMACOLOGY & THERAPEUTICS

Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist

(2010) Zuzana Justinová et al.   ADDICTION BIOLOGY

Adenosine-cannabinoid receptor interactions. Implications for striatal function

(2010) Sergi Ferré et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission

(2010) Alberto Martire et al.   JOURNAL OF NEUROCHEMISTRY

Endocannabinoid Signaling Mediates Psychomotor Activation by Adenosine A2A Antagonists

(2010) T. N. Lerner et al.   JOURNAL OF NEUROSCIENCE

Tuning and Fine-Tuning of Synapses with Adenosine

(2009) A. Sebastiao et al.   Current Neuropharmacology

Adenosine A2Areceptors enable the synaptic effects of cannabinoid CB1receptors in the rodent striatum

(2009) Maria Teresa Tebano et al.   JOURNAL OF NEUROCHEMISTRY

Caffeine drinking potentiates cannabinoid transmission in the striatum: Interaction with stress effects

(2008) Silvia Rossi et al.   NEUROPHARMACOLOGY